Insider Trading & Ownership - Rombotis Spiro George

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Rombotis Spiro George
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-12-21
Purchase
2023-12-26
4:05 pm
Cyclacel Pharmaceuticals Inc.CYCCRombotis Spiro George
President and CEO
6,070$3.315$20,12274,728
(Direct)
View
2021-11-18
Purchase
2021-11-22
4:05 pm
Cyclacel Pharmaceuticals Inc.CYCCRombotis Spiro George
President and CEO
4,000$4.5$18,0004,988
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-06-30
Option Award
2023-07-03
4:58 pm
2024-06-30
2033-06-30
Cyclacel Pharmaceuticals Inc.CYCCRombotis Spiro George
President and CEO
110,000$0110,000
(Direct)
View
2023-01-31
Option Award
2023-02-02
4:18 pm
N/A
N/A
Cyclacel Pharmaceuticals Inc.CYCCRombotis Spiro George
President and CEO
57,600$062,588
(Direct)
View
2021-12-13
Option Award(A)
2021-12-16
4:16 pm
N/A
2031-12-13
Cyclacel Pharmaceuticals Inc.CYCCRombotis Spiro George
President and CEO
190,000$0190,000
(Direct)
View
2021-12-13
Option Award
2021-12-15
4:20 pm
N/A
2031-12-13
Cyclacel Pharmaceuticals Inc.CYCCRombotis Spiro George
President and CEO
190,000$0190,000
(Direct)
View
2020-12-11
Option Award
2020-12-15
4:25 pm
N/A
2030-12-11
Cyclacel Pharmaceuticals Inc.CYCCRombotis Spiro George
President and CEO
175,000$0175,000
(Direct)
View
2019-12-05
Option Award
2019-12-09
9:01 pm
N/A
2027-12-29
Cyclacel Pharmaceuticals Inc.CYCCRombotis Spiro George
President and CEO
31,250$031,250
(Direct)
View
(A) Indicate amendment filing.